1例多元药物过敏急性胰腺炎患者行药物激发试验的药学监护

doi:10.19803/j.1672-8629.20220690

中国药物警戒 ›› 2023, Vol. 20 ›› Issue (7): 822-824.
DOI: 10.19803/j.1672-8629.20220690

1例多元药物过敏急性胰腺炎患者行药物激发试验的药学监护

刘婧¹, 夏亮², 张世杰^3,*

¹南昌大学第一附属医院药学部,江西南昌330000;
²南昌大学第一附属医院消化科,江西南昌330000;
³广东省人民医院赣州医院药剂科,江西赣州 341000

收稿日期:2022-11-30 出版日期:2023-07-15 发布日期:2023-07-14
通讯作者: ^*张世杰,男,本科,主管药师,临床药学。E-mail:ty41980622@qq.com
作者简介:刘婧,女,硕士,主管药师,临床药学。
基金资助:
江西省自然科学基金资助项目（20202BAB206010）; 江西省教育厅课题（GJJ180136）

Pharmaceutical care of a patient with acute pancreatitis complicated with multiple drug allergy undergoing drug stimulation test

LIU Jing¹, XIA Liang², ZHANG Shijie^3,*

¹Department of Pharmacy, the First Affiliated Hospital of Nanchang Medical University, Nanchang Jiangxi 330000, China;
²Department of Gastroenterology, the First Affiliated Hospital of Nanchang Medical University, Nanchang Jiangxi 330000, China;
³Department of Pharmacy, Guangdong Provincial People’s Hospital Ganzhou Hospital, Ganzhou Jiangxi 341000, China

Received:2022-11-30 Online:2023-07-15 Published:2023-07-14

摘要/Abstract

摘要： 目的探讨多元药物过敏急性胰腺炎患者行药物激发试验药学监护的策略,为多元药物过敏患者药学监护提供参考。方法临床药师参与1例多元药物过敏的急性胰腺炎患者的会诊,对患者的既往过敏病史（对左氧氟沙星、哌拉西林他唑巴坦、丙基硫氧嘧啶过敏,先锋霉素V皮肤过敏试验阳性）进行评估分析,建议行药物激发试验明确药物过敏诊断,并根据患者病情及药物激发试验结果提出用药建议。结果患者急性胰腺炎合并感染,进行β-内酰胺类抗生素规范化皮试及头孢哌酮舒巴坦的药物激发试验,结果为阴性,遂选用头孢哌酮舒巴坦（3 g q8h）进行抗感染治疗,期间无过敏反应发生。治疗期间临床药师对患者进行全程药学监护。结论药品过敏史评估与药物激发试验对于多元药物过敏患者抗菌药物选择策略十分重要,临床药师应结合临床实际与患者情况,协助医生制定治疗方案,对患者进行全程药学监护,保证其用药的安全性与有效性。

关键词: 急性胰腺炎, 多元药物过敏, 药物激发性试验, 抗菌药物, 头孢哌酮舒巴坦, 合理用药, 临床药师, 药学监护

Abstract: Objective To explore the pharmaceutical care strategy for a patient with acute pancreatitis complicated with multidrug allergy who underwent drug stimulation test, and to provide reference for pharmaceutical care of patients with multidrug allergy. Methods A clinical pharmacist participated in the consultation for a patient with acute pancreatitis complicated with multidrug allergy, analyzed the patient’s previous allergic history, recommended the drug provocation test to justify the diagnosis of drug allergy, and suggested medications based on the patient’s condition and results of the drug provocation test. Results The patient was diagnosed with acute pancreatitis complicated with infection. The standardized skin test of β-lactam antibiotics and the drug stimulation test of cefoperazone sulbactam were negative, so cefoperazone sulbactam (3 g q8h) was selected for anti-infection treatment. No allergic reactions occurred during the treatment. The clinical pharmacist provided whole-course pharmaceutical care for this patient. Conclusion The evaluation of drug sensitivity and allergy history and drug provocation tests are critical to the selection of antibiotics in patients with multiple drug allergy. Clinical pharmacists should assist doctors in formulating treatment plans and carrying out whole-process pharmaceutical care for patients so as to ensure the safety and effectiveness of drugs.

Key words: acute pancreatitis, multiple drug allergy, drug provocation test, antibacterial drugs, cefoperazone sulbactam, rational use, clinical pharmacist, pharmaceutical care

中图分类号:

刘婧, 夏亮, 张世杰. 1例多元药物过敏急性胰腺炎患者行药物激发试验的药学监护[J]. 中国药物警戒, 2023, 20(7): 822-824.

LIU Jing, XIA Liang, ZHANG Shijie. Pharmaceutical care of a patient with acute pancreatitis complicated with multiple drug allergy undergoing drug stimulation test[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 822-824.

[1]	范凯凯, 王聪, 刘洪峰, 王西勇. 临床药师对某院丙氨酰谷氨酰胺注射液应用干预分析[J]. 中国药物警戒, 2024, 21(2): 181-184.
[2]	李应芬, 韩雷. 319例注射用脑蛋白水解物药品不良反应报告分析[J]. 中国药物警戒, 2024, 21(2): 195-198.
[3]	黎杏仁, 沈爱宗, 苏丹. 质子泵抑制剂预防胆胰外科围术期应激性黏膜病变的合理性评价[J]. 中国药物警戒, 2023, 20(9): 1022-1026.
[4]	史香芬, 孙志勇, 张旭锋, 卢晓静, 杜书章, 张晓坚. 基于智能信息管理系统的门诊麻精药品全流程管理[J]. 中国药物警戒, 2023, 20(8): 899-903.
[5]	霍艳飞, 田月洁, 许莉莉, 谢彦军, 常虹, 孙春晓, 李霞. 535例氢溴酸高乌甲素制剂新的和严重的药品不良反应报告分析[J]. 中国药物警戒, 2023, 20(8): 921-926.
[6]	张夏兰, 袁静, 吴斌, 秦媛媛. 甲磺酸阿帕替尼在恶性肿瘤患者的用药特征分析[J]. 中国药物警戒, 2023, 20(8): 927-932.
[7]	王然, 李轶凡, 刘小艳, 冯欣. 1例妊娠期药物暴露风险的药学监护[J]. 中国药物警戒, 2023, 20(8): 933-934.
[8]	黄翠丽, 高奥, 王嘉熙, 郭海丽, 徐晓涵, 程吟楚, 郭代红. 抗菌药物相关血小板减少症的自动监测与评价研究[J]. 中国药物警戒, 2023, 20(7): 807-811.
[9]	陈婕, 秦侃. 肠外营养个体化给药实践评价[J]. 中国药物警戒, 2023, 20(7): 812-816.
[10]	张青霞, 周柳君, 李晓玲, 王育琴. 老年人头孢哌酮舒巴坦用药错误报告分析与建议[J]. 中国药物警戒, 2023, 20(5): 574-578.
[11]	范秀丛, 董晓慧, 陈丹霞, 鲍思蔚, 马雅斌. 1例妊娠期艰难梭菌感染伴尿路感染患者的药学监护[J]. 中国药物警戒, 2023, 20(5): 579-582.
[12]	杨岩, 周德喜, 吴欣俐, 薛淑雅, 丁海华, 张泉, 张云玲. 84例新型抗肿瘤药品不良反应报告分析[J]. 中国药物警戒, 2023, 20(3): 334-338.
[13]	殷进军, 王淑伟, 邵姜超, 王冰. 基于加权TOPSIS法的贝伐珠单抗注射液药物利用评价[J]. 中国药物警戒, 2023, 20(12): 1421-1426.
[14]	姚鑫, 葛秋格, 李亚敏, 王一帆, 李媛媛, 刘志强. 2018~2022年某院新型抗肿瘤药物消化系统不良反应分析[J]. 中国药物警戒, 2023, 20(11): 1273-1278.
[15]	郑金凤, 王景红. 1例多药联用致室性心律失常的药学监护[J]. 中国药物警戒, 2023, 20(11): 1279-1281.

1例多元药物过敏急性胰腺炎患者行药物激发试验的药学监护

Pharmaceutical care of a patient with acute pancreatitis complicated with multiple drug allergy undergoing drug stimulation test

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics